Showing all 4 results

    Cytokine Response Profile



    Alterations in the immune system that result in chronic inflammation and autoimmunity have been linked to a wide range of health conditions and diseases. Cytokines are important mediators of many immune responses, and imbalances in cytokines have been shown to play key roles on chronic inflammation and autoimmunity.

    Most cytokines can be generally characterized as pro-inflammatory or anti-inflammatory, depending on their primary effects on immune responses. Immune responses are often further characterized by the type of T helper (Th) cell involved.

    CytoDx® Panel Enables Practitioners to Assess Systemic Immune Status:

    • Pro-inflammatory / anti-inflammatory cytokine balance
    • Th1, Th2, Th17 and T-regulatory cytokine responses
    • Efficacy of immune balancing and modulating approaches

    Genomic Insight


    Experience the Difference of AI-Powered DNA Testing with Genomic Insight

    Diagnostic Solutions is pleased to offer clinicians the Genomic Insight ™ Genomic Health Profile
    powered by Opus23 Explorer ™ . Unlike any other DNA test on the market, Genomic Insight ™ uses
    the most advanced artificial intelligence to allow clinicians unique insight into patient genomics.
    Using the Opus23 ® informatics platform, clinicians can now customize reports using an
    interactive dashboard that curates a patient’s genomic data in “real-time” by using the latest
    medical-literature databases and meta-data sets.

    Genomic Insight ™  reports on over 5,000 single nucleotide polymorphisms (SNPs) in one
    comprehensive functional DNA test. Online results include therapeutic recommendations backed by
    the latest medical literature from PubMed, GWAS (genome wide association study), dbSNP,
    HapMap (haplotype map) and several others.

    Data gleaned from Genomic Insight ™ informatics uses the latest medical literature to provide relevant
    information on nutraceuticals, nutritional supplements, diet, and lifestyle interventions that can
    proactively influence a patient’s SNPs to reduce or prevent disease risk. Furthermore,
    pharmacogenomic results included in the profile allow practitioners to predict the efficacy of select
    pharmaceuticals tailored the individual’s genetic make-up.

    Advancing Personalized Medicine through Empowered DNA Testing
    DNA Testing for Health Optimization

    Research has shown that while some SNP’s may be beneficial to patient health, others carry
    significant health risks. Genomic Insight ™ equips you and your patients with the data analysis and
    knowledge needed to optimize health on an individual level. By taking into account each patient’s
    unique genomics, practitioners can be proactive in preventing illness before it begins, and even
    influence some diseases already in progress.

    Areas Evaluated

    • Methylation
    • Detoxification
    • Cognition
    • Inflammation
    • Anti-Aging
    • Endocrine
    • Structural
    • Energy/Metabolism
    • Estrogen Genomics
    • Androgen Genomics
    • Cardiometabolic
    • Gastrointestinal



    GI-MAP | GI Microbial Assay Plus

    Overwhelmingly, research indicates that gut health impacts overall health. The gut microbiome, in particular, plays a critical role in mediating the effects of diet and other factors on health, including digestive, immune, metabolic and neuroendocrine functions. Assessing GI health with the proper tools can help practitioners get to the root cause of chronic illness.

    The GI-MAP (Microbial Assay Plus) is unique in the field of comprehensive stool testing. It relies exclusively on quantitative polymerase chain reaction (qPCR) technology to detect parasites, bacteria, fungi, and more, by targeting the specific DNA of the organisms tested.

    Reliability with qPCR Technology

    Unlike other comprehensive stool tests on the market, the GI-MAP can provide practitioners with truly quantitative results. qPCR offers a much more accurate way to detect and quantify clinically-relevant organisms than standard PCR, culture, microscopy, or DNA sequencing-based methods. Accurately assessing how much of an organism’s DNA is present in a patient’s stool sample is essential for helping practitioners to determine the clinical significance of pathogenic organisms and dysbiosis patterns.

    Although qPCR is becoming more commonplace in in-vitro diagnostics (IVD), we are the only laboratory in the United States exclusively using qPCR technology for advanced comprehensive stool testing. This technology is used routinely in clinical and academic research because it provides highly-accurate quantification, as well as high levels of sensitivity and specificity. Standard PCR technology doesn’t offer the same level of sensitivity, or the ability to express precise numerical results.

    The GI-MAP also provides consistently reproducible results. Reproducibility is of crucial importance to the practitioners and patients that rely on the efficacy of the GI-MAP. To achieve it, we perform rigorous quality control, and have validated all molecular target quantification assays to meet or exceed FDA standards.

    This test is useful for

    • Autoimmune diseases
    • IBS/IBD
    • Digestive complaints, diarrhea or constipation
    • Brain fog
    • Skin problems, like acne and psoriasis
    • Mood disorders, depression, and anxiety
    • Diabetes and weight loss issues
    • Autoimmune diseases
    • IBS/IBD
    • Digestive complaints, diarrhea or constipation
    • Brain fog
    • Skin problems, like acne and psoriasis
    • Mood disorders, depression, and anxiety
    • Diabetes and weight loss issues

    H. pylori Profile


    Definitive Results from One Biopsy

    Our comprehensive H. pylori DNA Biopsy Profile offers the latest Real-Time qPCR Molecular Technology. DNA based testing offers significant advantages to other methods. Including testing for Antibiotic Resistance Genes and Virulence Factors.

    Patient treatment efficacy is greatly improved with phenotypic antibiotic resistance testing to guide treatment protocols. Additionally, Virulence Factor testing can help to identify the symptoms that H. pylori is contributing to and potential to cause disease.

    The H. pylori Biopsy Analysis Includes:

    • Helicobacter pylori
    • Antibiotic Resistance Genes, phenotype
    • Clarithromycin
    • Floroquinolones (Levofloxacin)
    • Amoxicillin
    • Tetracycline